Clinical Trials
66
Active:4
Completed:31
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:3
Phase 2:9
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (56 trials with phase data)• Click on a phase to view related trials
Not Applicable
29 (51.8%)Phase 2
9 (16.1%)Phase 4
9 (16.1%)Phase 3
5 (8.9%)Phase 1
3 (5.4%)Early Phase 1
1 (1.8%)Tranexamic Acid for The Management of Bleeding Gastrointestinal Angioectasias
Not Applicable
Completed
- Conditions
- AnemiaSmall Bowel BleedingAngioectasias
- Interventions
- Drug: Tranexamic Acid (TXA) treatmentDrug: Placebo
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Target Recruit Count
- 40
- Registration Number
- NCT07125508
- Locations
- 🇺🇸
LSU Health Sciences Center - New Orleans, New Orleans, Louisiana, United States
Clinical Evaluation of no Needle Dental Anesthesia Compared to Syringe Anesthesia Delivery
Early Phase 1
Active, not recruiting
- Conditions
- Local Anesthesia Injection Pain
- Interventions
- Drug: Iontophoresis of Tetracaine and oxymetazolineDrug: Local Anesthesia (lidocaine hydrochloride)
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-06-26
- Target Recruit Count
- 20
- Registration Number
- NCT06874244
- Locations
- 🇺🇸
LSUHSC School of Dentistry, New Orleans, Louisiana, United States
Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain
Not Applicable
Recruiting
- Conditions
- Sickle Cell DiseaseVaso-occlusive Pain Episodes
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Target Recruit Count
- 36
- Registration Number
- NCT06773715
- Locations
- 🇺🇸
Children's Hospital of New Orleans, New Orleans, Louisiana, United States
The Effect of Increasing Dietary Protein on the Gut Microbiome and Its Metabolites
Not Applicable
Completed
- Conditions
- Health Adults
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2024-11-06
- Target Recruit Count
- 87
- Registration Number
- NCT06677333
- Locations
- 🇺🇸
Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana, United States
Optimal Injection Interval for Intra-Detrusor Botulinum Toxin
Not Applicable
Not yet recruiting
- Conditions
- Urinary IncontinenceOveractive BladderUrinary UrgencyUrge Urinary Incontinence
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2024-07-17
- Target Recruit Count
- 100
- Registration Number
- NCT06483217
- Locations
- 🇺🇸
Louisiana State University Health Science Center, New Orleans, Louisiana, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
News
No news found